Real-world experience with ombitasvir/paritaprevir boosted with ritonavir and possibly combined with dasabuvir and ribavirin in HCV infection

Ombitasvir/paritaprevir boosted with ritonavir and possibly combined with dasabuvir and ribavirin (OBV/PTV/r ± DSV ± RBV) is a new direct-acting antiviral (DAA) regimen which has improved efficacy of chronic hepatitis C virus (HCV) treatment significantly. OBV/PTV/r ± DSV ± RBV in clinical trials de...

Descripción completa

Detalles Bibliográficos
Autores principales: Pogorzelska, Joanna, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497406/
https://www.ncbi.nlm.nih.gov/pubmed/28856270
http://dx.doi.org/10.5114/ceh.2016.60247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497406/
https://www.ncbi.nlm.nih.gov/pubmed/28856270
http://dx.doi.org/10.5114/ceh.2016.60247

Ejemplares similares